pharma · Malaria · Pharmacokinetics · CNSP
CNS Pharmaceuticals
CNS Pharmaceuticals is a pharma organization headquartered in Houston, USA. It trades on NYSE under ticker CNSP. Primary therapeutic focus areas include Malaria, Pharmacokinetics, Ovarian Cancer, Glioblastoma multiforme
Houston, TX 77027, US HQ
2017 Founded
12 Employees
Public company Type
CNSP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Houston, TX 77027, US
- Founded
- 2017
- Employees
- 12
- Programs
- 21
- Drugs
- 18
- Patents
- 0
(+)-SJ000557733
Phase 1 · small molecule · Plasmodium Falciparum Malaria
(+)-SJ000557733 for Plasmodium Falciparum Malaria is a Phase 1 program (small_molecule) at CNS Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code QP15C20
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CNS Pharmaceuticals
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Plasmodium Falciparum Malaria
- Status
- completed
- Trials
- 1